Skip to main content
. Author manuscript; available in PMC: 2011 Mar 1.
Published in final edited form as: Cancer Chemother Pharmacol. 2009 Aug 1;65(4):775–780. doi: 10.1007/s00280-009-1084-8

Table 2.

Key Characteristics of Cancer Patients by Presence or Absence of DLT (N=242)

Characteristic DLT Present (N=63)
DLT Absent (N=173)
p-value
% or Mean % or Mean
Age (years), mean(SD) 60.2 (13.4) 56.2 (12.6) 0.039
Gender, %(N)
 Male 55.6 (35) 56.7 (98) 0.883
 Female 44.4 (28) 43.4 (75)
Marital Status, %(N)
 Single 9.8 (6) 19.3 (32) 0.110
 Married 90.2 (55) 80.7 (134)
Census Zip Code Median Houshold Income in $1000s, mean(SD) 50.4 (11.7) 46.4 (11.3) 0.029
Percent of Census Block Aged 25+ with a Bachelor’s Degree, mean(SD) 15.5 (6.5) 15.8 (7.1) 0.748
Distance to Hospital (miles), mean(SD) 72.5 (47.9) 91.2 (81.8) 0.091
Smoking Status, %(N)
 Never a Smoker 47.3 (26) 40.5 (60)
 Former Smoker 43.6 (24) 42.6 (63) 0.375
 Current Smoker 9.1 (5) 16.9 (25)
Number of Pack Years, mean(SD) 18.7 (27.8) 18.3 (23.2) 0.915
Height (cm), mean(SD) 170.5 (11.5) 171.3 (10.8) 0.621
Weight (Kg), mean(SD) 75.4 (15.4) 81.9 (20.5) 0.023
Body Surface Area (m2), mean(SD) 1.88 (0.23) 1.96 (0.28) 0.039
Dose, %(N)
 MTD 31.8 (20) 54.9 (95) 0.002
 Above MTD 68.3 (43) 45.1 (78)
Duration of Diagnosis in months, mean(SD) 25.5 (26.7) 32.3 (38.3) 0.196
Number of Prior Therapies, mean(SD) 2.4 (1.9) 2.5 (1.7) 0.825
Numer of Medications, mean(SD) 4.5 (3.7) 4.4 (3) 0.927
CIR-G Total Score, mean(SD) 7.3 (2.5) 7.5 (2.6) 0.651
ECOG-PS, %(N)
 Restricted 80.3 (49) 71.3 (119) 0.179
 Fully Active 19.7 (12) 28.7 (48)
Lab Data, mean(SD)
 ALK PHOS (U/L) 184.6 (165.5) 141.7 (113.2) 0.029
 WBC (K/uL) 7 (2.5) 7.2 (4.1) 0.692
 ANC (cells/uL) 5030.1 (2349.3) 4931.8 (2398.3) 0.783
 HGB (K/uL) 12.1 (1.5) 12.6 (1.7) 0.044
 PLT (K/uL) 268.6 (113.6) 267.8 (99.4) 0.960
 CREAT (mg/dL) 0.9 (0.2) 0.9 (0.2) 0.680
 ALB (g/dL) 3.5 (0.5) 3.7 (0.5) 0.056
 LDH (U/L) 537 (854.9) 290.9 (234) 0.002

Bold indicates P<.05